source
- Researchers claim small molecules could reprogram cells, hinting at a future anti‑aging pillScientists have identified tiny compounds that appear to reset cells to a more youthful condition, according to a recent report featuring David Sinclair’s lab. The molecules work by altering cellul…
- Regeneron explores pairing its obesity drug with lipid-lowering therapy to differentiate in crowded GLP-1 marketThe pipeline of GLP-1 based medicines is delivering increasingly strong weight-loss results, prompting many companies to seek ways to stand out as the market fills. Regeneron said it is looking at…